NovaPoint Capital’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-20,514
Closed -$488K – 139
2024
Q1
$488K Sell
20,514
-3,538
-15% -$84.2K 0.17% 85
2023
Q4
$576K Buy
24,052
+13,462
+127% +$314K 0.21% 82
2023
Q3
$245K Buy
+10,590
New +$247K 0.1% 114

Other funds holding IBDS

NovaPoint Capital's IBDS Position: Q2 2024 in Review

NovaPoint Capital sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q2 2024, closing a stake of 20,514 shares — an estimated $488K sold.

NovaPoint Capital first reported a position in IBDS in Q3 2023 and held it in 3 quarters. The position peaked at $576K in Q4 2023. 307 funds tracked by Wall St. Rank hold IBDS as of Q2 2024.

  • NovaPoint Capital reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q2 2024 after selling out during the quarter.
  • NovaPoint Capital sold 20,514 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2024, an estimated $488K.
  • NovaPoint Capital first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2023 and held it in 3 quarters.
  • NovaPoint Capital's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $576K in Q4 2023.
  • 307 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2024.

Based on NovaPoint Capital's 13F filing for Q2 2024, filed 10 Jul 2024.